|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...6162636465666768697071...110111» |
- alvocidib (DSP-2033) / Sumitomo Pharma
Trial initiation date: Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors (clinicaltrials.gov) - Aug 12, 2014
P2, N=50, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Initiation date: May 2013 --> Jun 2009
- |||||| Solithera (solithromycin) / Melinta Therap, Fujifilm Holdings
Enrollment open: SOLITAIRE-U: Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea (clinicaltrials.gov) - Aug 12, 2014
P3, N=300, Recruiting, Sponsor: Cempra Pharmaceuticals
Initiation date: May 2013 --> Jun 2009 Not yet recruiting --> Recruiting
- Trial primary completion date: Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease (clinicaltrials.gov) - Aug 11, 2014
P=N/A, N=94, Recruiting, Sponsor: Children's Hospital of Philadelphia
Not yet recruiting --> Recruiting Trial primary completion date: Jul 2014 --> Nov 2014
- carboplatin / Generic mfg., paclitaxel / Generic mfg.
Preclinical, Enrollment change, Trial withdrawal: IClyCO: Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer (clinicaltrials.gov) - Aug 11, 2014
P=N/A, N=0, Withdrawn, Sponsor: Rennes University Hospital
Trial primary completion date: Jul 2014 --> Nov 2014 N=30 --> 0 | Not yet recruiting --> Withdrawn
- Enrollment closed: The Valve of Hyaluronic Binding Selection (PICSI) in Improving IVF Outcome (clinicaltrials.gov) - Aug 11, 2014
P=N/A, N=60, Active, not recruiting, Sponsor: St. Luke's-Roosevelt Hospital Center
N=30 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Active, not recruiting
- ||| Enrollment closed: Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions (clinicaltrials.gov) - Aug 11, 2014
P2, N=300, Active, not recruiting, Sponsor: Ferring Pharmaceuticals
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Enrollment closed, Trial primary completion date: The Value of HBA in the Evaluation of Idiopathic Infertility (clinicaltrials.gov) - Aug 11, 2014
P=N/A, N=80, Active, not recruiting, Sponsor: St. Luke's-Roosevelt Hospital Center
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2014 --> Jan 2015
- epacadostat (INCB024360) / Incyte
Enrollment open: Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (clinicaltrials.gov) - Aug 8, 2014
P1, N=20, Recruiting, Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2014 --> Jan 2015 Not yet recruiting --> Recruiting
- | Granocyte (lenograstim) / Roche
Trial completion, Surgery: EORTC-STBSG 62931: Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma (clinicaltrials.gov) - Aug 8, 2014
P3, N=350, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- sirolimus / Generic mfg.
Trial primary completion date: Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (clinicaltrials.gov) - Aug 7, 2014
P1, N=30, Recruiting, Sponsor: Roswell Park Cancer Institute
Active, not recruiting --> Completed Trial primary completion date: Sep 2014 --> Sep 2016
- trebananib (AMG 386) / Amgen
Enrollment closed: Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer (clinicaltrials.gov) - Aug 7, 2014
P2, N=55, Active, not recruiting, Sponsor: Gynecologic Oncology Group
Trial primary completion date: Sep 2014 --> Sep 2016 Suspended --> Active, not recruiting
- cisplatin / Generic mfg., paclitaxel / Generic mfg., doxorubicin hydrochloride / Generic mfg.
Enrollment closed: Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer (clinicaltrials.gov) - Aug 7, 2014
P1, N=60, Active, not recruiting, Sponsor: Gynecologic Oncology Group
Suspended --> Active, not recruiting Recruiting --> Active, not recruiting
- Enrollment change, Trial primary completion date: IMSI in Couples With Previous Implantation Failures (clinicaltrials.gov) - Aug 6, 2014
P=N/A, N=186, Recruiting, Sponsor: Sapientiae Institute
Recruiting --> Active, not recruiting N=386 --> 186 | Trial primary completion date: Jun 2015 --> Oct 2014
- pioglitazone / Generic mfg.
Enrollment change, Trial termination: Effects of Pioglitazone on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS) (clinicaltrials.gov) - Aug 6, 2014
P=N/A, N=36, Terminated, Sponsor: Virginia Commonwealth University
N=386 --> 186 | Trial primary completion date: Jun 2015 --> Oct 2014 N=66 --> 36 | Active, not recruiting --> Terminated; Lack of recruitment
- azithromycin / Generic mfg.
Trial completion, Trial primary completion date: Expedited Partner Therapy for MSM in Peru (clinicaltrials.gov) - Aug 6, 2014
P=N/A, N=165, Completed, Sponsor: University of California, Los Angeles
N=66 --> 36 | Active, not recruiting --> Terminated; Lack of recruitment Recruiting --> Completed | Trial primary completion date: Jul 2013 --> Aug 2014
- ENMD-2076 / CASI
Trial completion: Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer (clinicaltrials.gov) - Aug 6, 2014
P2, N=64, Completed, Sponsor: CASI Pharmaceuticals, Inc.
Recruiting --> Completed | Trial primary completion date: Jul 2013 --> Aug 2014 Active, not recruiting --> Completed
- Trial primary completion date, HEOR, Surgery: Lymphedema in Endometrial Cancer (clinicaltrials.gov) - Aug 6, 2014
P=N/A, N=100, Recruiting, Sponsor: Duke University
Active, not recruiting --> Completed Trial primary completion date: Dec 2014 --> Dec 2015
- menotropin / Generic mfg.
Enrollment change: Highly Purified Menotropin (HP-hMG) Versus Recombinant FSH (rFSH) Plus Recombinant LH (rLH) in Intrauterine Insemination Cycles in Women ?35 Years: a Prospective Randomized Trial. (clinicaltrials.gov) - Aug 6, 2014
P1, N=579, Completed, Sponsor: Catholic University of the Sacred Heart
Trial primary completion date: Dec 2014 --> Dec 2015 N=300 --> 579
- ||| Clinical: FILM: A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping (clinicaltrials.gov) - Aug 6, 2014
P=N/A, N=150, Not yet recruiting, Sponsor: Novadaq Technologies Inc.
- |||||||||| Solithera (solithromycin) / Melinta Therap, Fujifilm Holdings
New P3 trial: SOLITAIRE-U: Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea (clinicaltrials.gov) - Aug 6, 2014
P3, N=300, Not yet recruiting, Sponsor: Cempra Pharmaceuticals
- |||| Visanne (dienogest) / Mochida, Bayer
Trial primary completion date: Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis (clinicaltrials.gov) - Aug 5, 2014
P3, N=312, Active, not recruiting, Sponsor: Bayer
N=300 --> 579 Trial primary completion date: Jun 2014 --> Mar 2014
- Trial primary completion date: Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC) (clinicaltrials.gov) - Aug 5, 2014
P=N/A, N=150, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Jun 2014 --> Mar 2014 Trial primary completion date: Feb 2015 --> Feb 2016
- Enrollment change, Trial termination: A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes (clinicaltrials.gov) - Aug 5, 2014
P2, N=8, Terminated, Sponsor: Devirex AG
Trial primary completion date: Feb 2015 --> Feb 2016 N=25 --> 8 | Recruiting --> Terminated; insufficient patient recruitment
- Clinical: Differences in Ovarian Reserve Markers and Vitamin D Between Infertile Indian, Arabian and Caucasian Population (clinicaltrials.gov) - Aug 5, 2014
P=N/A, N=600, Not yet recruiting, Sponsor: IVI Madrid
- | Enrollment closed, Enrollment change, Trial primary completion date: DITTO: Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian Aging (clinicaltrials.gov) - Aug 5, 2014
P3, N=60, Active, not recruiting, Sponsor: University of Nottingham
N=25 --> 8 | Recruiting --> Terminated; insufficient patient recruitment Recruiting --> Active, not recruiting | N=80 --> 60 | Trial primary completion date: Sep 2013 --> Nov 2014
- ||| Biomarker, Trial completion, Enrollment change, Trial primary completion date, Biomarker assay: New Biomarkers Evaluating Ovarian Cancer (clinicaltrials.gov) - Aug 5, 2014
P=N/A, N=280, Completed, Sponsor: Fujirebio Diagnostics, Inc.
Recruiting --> Active, not recruiting | N=80 --> 60 | Trial primary completion date: Sep 2013 --> Nov 2014 Recruiting --> Completed | N=500 --> 280 | Trial primary completion date: Dec 2015 --> Mar 2014
- | buparlisib (AN2025) / Novartis, Adlai Nortye
Trial initiation date, Trial primary completion date, Metastases: Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer (clinicaltrials.gov) - Aug 5, 2014
P2, N=27, Not yet recruiting, Sponsor: Novartis Pharmaceuticals
Recruiting --> Completed | N=500 --> 280 | Trial primary completion date: Dec 2015 --> Mar 2014 Initiation date: Feb 2015 --> Jul 2015 | Trial primary completion date: Dec 2015 --> Sep 2017
- Ixempra (ixabepilone) - Otsuka, R / Pharm, Allarity Therap
Trial completion, Metastases: Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer (clinicaltrials.gov) - Aug 5, 2014
P1/2, N=46, Completed, Sponsor: National Cancer Institute (NCI)
Initiation date: Feb 2015 --> Jul 2015 | Trial primary completion date: Dec 2015 --> Sep 2017 Active, not recruiting --> Completed
- 5-fluorouracil / Generic mfg., cisplatin / Generic mfg.
Metastases: Cisplatin Plus One-Day 24-hour Infusion of High-Dose 5-Fluorouracil for Stage IVB, Recurrent or Metastatic Carcinoma of the Uterine Cervix (clinicaltrials.gov) - Aug 4, 2014
P=N/A, N=30, Recruiting, Sponsor: National Taiwan University Hospital
- Trial primary completion date: Use of a Synthetic Macromolecule (Hydroxypropyl Cellulose ) and Trehalose as Additives for Oocyte Vitrification (clinicaltrials.gov) - Aug 1, 2014
P=N/A, N=402, Active, not recruiting, Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA
Active, not recruiting --> Completed Trial primary completion date: May 2013 --> Dec 2014
- Enrollment open, Trial primary completion date: Closed Vitrification of Oocytes (clinicaltrials.gov) - Aug 1, 2014
P=N/A, N=604, Recruiting, Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA
Trial primary completion date: May 2013 --> Dec 2014 Active, not recruiting --> Recruiting | Trial primary completion date: Jul 2013 --> Mar 2015
- Trial primary completion date, Metastases: A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer (clinicaltrials.gov) - Aug 1, 2014
P1, N=42, Recruiting, Sponsor: Janssen Research & Development, LLC
Active, not recruiting --> Recruiting | Trial primary completion date: Jul 2013 --> Mar 2015 Trial primary completion date: Feb 2016 --> Mar 2015
- adavosertib (AZD1775) / AstraZeneca
Trial suspension, Combination therapy: AZD1775, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer (clinicaltrials.gov) - Aug 1, 2014
P1, N=57, Suspended, Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Feb 2016 --> Mar 2015 Recruiting --> Suspended
- Trial initiation date, HEOR: Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer (clinicaltrials.gov) - Aug 1, 2014
P=N/A, N=484, Not yet recruiting, Sponsor: City of Hope Medical Center
Recruiting --> Suspended Initiation date: Aug 2014 --> Dec 2014
- | Trial completion, Trial primary completion date: Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness (clinicaltrials.gov) - Aug 1, 2014
P0, N=21, Completed, Sponsor: ViroPan, Inc.
Initiation date: Aug 2014 --> Dec 2014 Recruiting --> Completed | Trial primary completion date: Jan 2015 --> May 2014
- | Trial completion, Licensing / partnership: Perinatal Infections in Pakistan (clinicaltrials.gov) - Jul 31, 2014
P=N/A, N=1500, Completed, Sponsor: NICHD Global Network for Women's and Children's Health
Recruiting --> Completed | Trial primary completion date: Jan 2015 --> May 2014 Recruiting --> Completed
- Preclinical, Trial primary completion date: Metabolomic Embryo Profiles of Obese in Vitro Fertilization (IVF) Patients and Their Relationship With Polycystic Ovary Syndrome (PCO) (clinicaltrials.gov) - Jul 30, 2014
P=N/A, N=45, Recruiting, Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA
Recruiting --> Completed Trial primary completion date: Oct 2012 --> Oct 2014
- | New P4 trial: Effects of Korean Red Ginseng on Male Infertility (clinicaltrials.gov) - Jul 30, 2014
P4, N=80, Completed, Sponsor: Pusan National University Hospital
- | New P4 trial: Effects of Korean Red Ginseng on Semen Parameters in Male Infertility Patients: a Randomized, Placebo-controlled, Double-blind Clinical Study (clinicaltrials.gov) - Jul 30, 2014
P4, N=80, Completed, Sponsor: Pusan National University Hospital
- polyvalent vaccine-KLH conjugate / MabVax, Avastin (bevacizumab) / Roche
Trial primary completion date, Combination therapy, IO biomarker: Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab (clinicaltrials.gov) - Jul 30, 2014
P=N/A, N=22, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Trial primary completion date: Oct 2012 --> Oct 2014 Trial primary completion date: Oct 2014 --> Oct 2015
- arsenic trioxide / Generic mfg.
Trial initiation date, Metastases: Trisenox (clinicaltrials.gov) - Jul 30, 2014
P2, N=5, Terminated, Sponsor: UNC Lineberger Comprehensive Cancer Center
Trial primary completion date: Oct 2014 --> Oct 2015 Initiation date: Feb 2012 --> Mar 2010
- Enrollment change: APACHE-2: Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention (clinicaltrials.gov) - Jul 30, 2014
P0, N=5998, Completed, Sponsor: University Hospital, Tours
Initiation date: Feb 2012 --> Mar 2010 N=323 --> 5998
- |||||| anastrozole/levonorgestrel (BAY 98-7196) / Bayer
New P2b trial: Bay98-7196, Dose Finding / POC Study (clinicaltrials.gov) - Jul 30, 2014
P2b, N=324, Not yet recruiting, Sponsor: Bayer
- | merigolix (TU2670) / Tium Bio, Daewon Pharma
New P1 trial: Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670 (clinicaltrials.gov) - Jul 30, 2014
P1, N=16, Recruiting, Sponsor: SK Chemicals Co.,Ltd.
- |||| ombrabulin (AVE8062) / Sanofi
Trial completion, Trial primary completion date: OPSALIN: Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel (clinicaltrials.gov) - Jul 30, 2014
P2, N=157, Completed, Sponsor: Sanofi
N=323 --> 5998 Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Jul 2014
- Enrollment closed, Trial primary completion date: Smoking Cessation in Women With Gynecological Conditions (clinicaltrials.gov) - Jul 27, 2014
P=N/A, N=31, Active, not recruiting, Sponsor: University of Oklahoma
Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Jul 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Apr 2015
- Clinical: Clinical Utility of Rapid CT/NG Testing in the ED (clinicaltrials.gov) - Jul 25, 2014
P=N/A, N=300, Not yet recruiting, Sponsor: Johns Hopkins University
- Enrollment closed, Trial primary completion date: OV-AP-ICG-IV: Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients (clinicaltrials.gov) - Jul 24, 2014
P1/2, N=10, Active, not recruiting, Sponsor: Jules Bordet Institute
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Apr 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2014 --> Oct 2014
- | Trial completion, Trial primary completion date: An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation (clinicaltrials.gov) - Jul 24, 2014
P3, N=149, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2014 --> Oct 2014 Active, not recruiting --> Completed | Trial primary completion date: Aug 2013 --> Jul 2014
- || Biomarker, Preclinical, Trial primary completion date: Next Generation Sequencing Screening for Embryonic Ploidy Status (clinicaltrials.gov) - Jul 23, 2014
P=N/A, N=250, Recruiting, Sponsor: Reproductive Medicine Associates of New Jersey
Active, not recruiting --> Completed | Trial primary completion date: Aug 2013 --> Jul 2014 Trial primary completion date: Jun 2014 --> Dec 2014